SCHEMBL2748847

SCHEMBL2748847

N#Cc1cccc2nc(I)sc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 2/20 0.44
PDE10A Q9Y233 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HTT P42858 2/20 0.35
GAA P10253 1/20 0.35
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
DYRK1A Q13627 1/20 0.32
TSHR P16473 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TRPA1 O75762 2/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30
MAP2K1 Q02750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25156246 0.79 PSMB8 (0.44) PSMB8PDE10AALDH1A1KDM4EHTT
SCHEMBL2748625 0.75 KDM4E (0.41) PSMB8PDE10AALDH1A1KDM4EHTT
SCHEMBL2749596 0.72 PSMB8 (0.36) PSMB8PDE10AALDH1A1KDM4EGAA
SCHEMBL2749649 0.72 BACE1 (0.36) PSMB8L3MBTL1
SCHEMBL18499847 0.71 NPC1 (0.31) SMN1; SMN2
SCHEMBL5474087 0.67 ALDH1A1 (0.41) PSMB8PDE10AALDH1A1KDM4EHTT
SCHEMBL30312186 0.66 ASH1L (0.46) PSMB8ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL20650733 0.66 DYRK1A (0.47) PDE10AALDH1A1KDM4EHTTGAA
SCHEMBL12778292 0.64 PSMB8 (0.44) PSMB8ALDH1A1KDM4EHTTGAA
SCHEMBL3236721 0.64 TSHR (0.46) ALDH1A1KDM4EHTTCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178668-B2 2-aminopyridine kinase inhibitors OSI Pharmaceuticals, LLC (US) 2012-05-15 US disclosed
EP-2265270-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI Pharmaceuticals, Inc. (US) 2010-12-29 EP disclosed
WO-2009099982-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2009-08-13 WO disclosed
US-20090197862-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197862-A1 2-AMINOPYRIDINE KINASE INHIBITORS ERBB2, ABL2, TIE1 PSMB8 4599/4885PDE10A 2965/4885ALDH1A1 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.